$257.78▼ 1.58 (0.61%)
Real-time prices · US Markets70% of 23 covering analysts have a positive rating.
earnings contracting 96% year-over-year.
Quality
6.2
Health
6.5
Growth
4.3
Valuation
6.5
Sentiment
7.4
Analyst Target
$279.41
▲ +8.4% from current
Price Chart
Latest News
Fundamentals
Trailing P/E
39.1×
price-to-earnings
Forward P/E
22.2×
next 12 months est.
Market Cap
$621.2B
market capitalization
Div Yield
2.08%
dividend yield
Profit Margin
16.2%
net profit margin
Gross Margin
67.8%
revenue minus COGS
ROE
—
return on equity
Beta
0.21
vs S&P 500
52-Week Range
$185 — $281
annual min — max
EPS — Estimate vs Actual
Frequently Asked Questions
What do analysts say about Johnson & Johnson right now?
Johnson & Johnson's Q·Score is 6.1/10 (Neutral), reflecting its current fundamentals, analyst data, and valuation metrics. 70% of 23 covering analysts have a positive rating. Key area to monitor: earnings contracting 96% year-over-year. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
What is the analyst price target for JNJ?
The consensus price target for JNJ is $279.41, based on ratings from 22 Wall Street analysts. This is 8.4% above the current price of $257.78. Price targets are forward-looking estimates and not guarantees of future performance.
Is JNJ overvalued or undervalued?
Johnson & Johnson (JNJ) scores in line with sector averages on valuation metrics. Its forward P/E ratio stands at 22.2×. The consensus analyst price target of $279.41 is 8% above the current price.
What is Johnson & Johnson's profit margin?
Johnson & Johnson has a net profit margin of 16.2%, which is solid for most industries. Its gross margin stands at 67.8%, indicating a high-margin business model.
What is JNJ's dividend yield?
Johnson & Johnson currently offers a dividend yield of 2.08%, which is above the typical market average dividend yield. Dividend yields can change based on price movements and company payout decisions.
Is Johnson & Johnson's revenue growing?
Johnson & Johnson is reporting modest revenue growth of 5.9%. However, earnings declined 96.0%, which warrants monitoring.
How much debt does Johnson & Johnson have?
Johnson & Johnson has a debt-to-equity ratio of 0.58×, reflecting a moderate debt level, which is manageable for most profitable companies.